Malaria, Vivax

Approved for this indication (5)

• mefloquine
• tafenoquine succinate
• primaquine
• halofantrine
• artemether

Phase 4 trials (6)

• artemisinin
• artesunate
• chloroquine
• lumefantrine
• piperaquine
• dihydroartemisinin

Phase 3 trials (5)

• dapsone
• sulfadoxine
• amodiaquine
• chlorproguanil
• pyrimethamine

Phase 2 trials (12)

• artefenomel
• dsm265
• momordica charantia
• tinidazole
• hepatitis b vaccine (recombinant)
• (+)-sj000557733
• chad63 pvdbp
• mva pvdbp
• vaccine pvcs n+c+r
• pvdbpii
• matrix m1
• PvRII

Phase 1 trials (10)

• budesonide
• isa-720
• pfs25-imx313
• moxifloxacin
• peptides (n, r & c) from p. vivax cs protein
• pppfs25
• scpvs25
• isa-51
• crotalidae antivenin polyvalent (equine)
• vivaxin

Organization Involved with Phase 4 Indications (18)

• Institut Pasteur
• National Institute of Allergy and Infectious Diseases (NIAID)
• Pan American Health Organization
• Mahidol University
• Menzies School of Health Research
• Tribhuvan University
• University of Oxford
• Wellcome Trust
• Tropical Diseases Hospital, Ho Chi Minh City
• Agency for Science, Technology and Research
• Nangarhar University
• Institute of Malaria, Parasitology and Entomology, Ho Chi Minh City, Vietnam
• National Malaria and Leishmaniasis Control Program, Afghanistan
• Instituto Nacional de Laboratorios de Salud (INLASA)
• Government of Bolivia
• Government of France
• Centers for Disease Control and Prevention (CDC)
• PATH

Organization Involved with Phase 3 Indications (22)

• Medicines for Malaria Venture
• World Health Organization
• Fundação de Medicina Tropical Dr. Heitor Vieira Dourado
• Addis Ababa University
• University of London
• University of Khartoum
• University of Melbourne
• Ethiopian Public Health Institute
• National Centre for Parasitology, Entomology and Malaria Control, Cambodia
• Government of Pakistan
• University of Sao Paulo
• HealthNet International, Peshawar, Pakistan
• University of Kassala
• Government of Brazil
• Shin Poong Pharmaceuticals
• HealthNet TPO
• United Nations
• Government of Afghanistan
• Government of Indonesia
• Government of Malaysia
• Oswaldo Cruz Foundation
• Universitas Sumatera Utara

Organization Involved with Phase 2 Indications (9)

• Leadiant Biosciences, Inc.
• United States Army
• Conselho Nacional de Desenvolvimento Científico e Tecnológico
• Jimma University
• University of Heidelberg
• University of Basel
• Asociación Civil Selva Amazónica
• Ludwig Maximilians University
• Malaria Research Unit, Thailand

Organization Involved with Phase 1 Indications (2)

• Parexel
• Malaria Vaccine and Drug Development Center

Organization Involved with Other Experimental Indications (8)

• Gadjah Mada University
• University of North Carolina at Chapel Hill
• Research Institute for Tropical Medicine, Alabang, Muntinlupa, Metro Manila, Philippines
• National Institute of Health Research and Development, Jakarta, Indonesia
• National Health and Medical Research Council, Australia
• Eijkman Institute for Molecular Biology, Jakarta, Indonesia
• Timika Research Facility, Indonesia
• Government of Thailand